Lu QS, Ma L, Jiang WJ, Wang XB, Lu M. Correction to: KAT7/HMGN1 signaling epigenetically induces tyrosine phosphorylation-regulated kinase 1A expression to ameliorate insulin resistance in Alzheimer’s disease. World J Psychiatry 2026; 16(4): 117493 [DOI: 10.5498/wjp.v16.i4.117493]
Corresponding Author of This Article
Mei Lu, MD, Professor, Department of Geriatric Medicine, Qilu Hospital of Shandong University, No. 107 Wenhua Xilu, Jinan 250012, Shandong Province, China. lumei@qiluhospital.com
Research Domain of This Article
Psychiatry
Article-Type of This Article
Correction
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Apr 19, 2026 (publication date) through Apr 2, 2026
Times Cited of This Article
Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Lu QS, Ma L, Jiang WJ, Wang XB, Lu M. Correction to: KAT7/HMGN1 signaling epigenetically induces tyrosine phosphorylation-regulated kinase 1A expression to ameliorate insulin resistance in Alzheimer’s disease. World J Psychiatry 2026; 16(4): 117493 [DOI: 10.5498/wjp.v16.i4.117493]
World J Psychiatry. Apr 19, 2026; 16(4): 117493 Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.117493
Correction to: KAT7/HMGN1 signaling epigenetically induces tyrosine phosphorylation-regulated kinase 1A expression to ameliorate insulin resistance in Alzheimer’s disease
Qun-Shan Lu, Lin Ma, Wen-Jing Jiang, Xing-Bang Wang, Mei Lu
Qun-Shan Lu, Lin Ma, Wen-Jing Jiang, Xing-Bang Wang, Mei Lu, Department of Geriatric Medicine, Qilu Hospital of Shandong University, Jinan 250012, Shandong Province, China
Lin Ma, Wen-Jing Jiang, Xing-Bang Wang, Mei Lu, Key Laboratory of Cardiovascular Proteomics of Shandong Province, Qilu Hospital of Shandong University, Jinan 250012, Shandong Province, China
Author contributions: Lu QS and Lu M designed the study; Lu QS, Ma L, Jiang WJ, and Wang XB performed the experiments; Lu QS and Lu M wrote the manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Mei Lu, MD, Professor, Department of Geriatric Medicine, Qilu Hospital of Shandong University, No. 107 Wenhua Xilu, Jinan 250012, Shandong Province, China. lumei@qiluhospital.com
Received: December 9, 2025 Revised: December 15, 2025 Accepted: January 23, 2026 Published online: April 19, 2026 Processing time: 111 Days and 23.6 Hours
Abstract
This is an erratum regarding the published paper titled “KAT7/HMGN1 signaling epigenetically induces tyrosine phosphorylation-regulated kinase 1A expression to ameliorate insulin resistance in Alzheimer’s disease”. We wish to report an inadvertent duplication in Figure 3B, where the third flow cytometry image was inadvertently duplicated. We confirm that this correction does not affect the interpretation of the results or the conclusions of the study.
Core Tip: This manuscript serves as an official erratum to correct an error in Figure 3B of the article “Lu QS, Ma L, Jiang WJ, Wang XB, Lu M. KAT7/HMGN1 signaling epigenetically induces tyrosine phosphorylation-regulated kinase 1A expression to ameliorate insulin resistance in Alzheimer’s disease. World J Psychiatry 2024; 14 (3): 445-455 PMID: 38617985 DOI: 10.5498/wjp.v14.i3.445”.
